{"article_title": "A Look At The Factors Driving Our $105 Price Estimate For UnitedHealth", "article_keywords": ["look", "driving", "factors", "price", "estimate", "105", "unitedhealth"], "article_url": "http://www.forbes.com/sites/greatspeculations/2015/02/23/a-look-at-the-factors-driving-our-105-price-estimate-for-unitedhealth/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Great Speculations", "og": {"site_name": "Forbes", "description": "The company posted solid growth figures in 2014, despite fears of an adverse impact from the implementation of the Affordable Care Act. The company's operating income and revenues both recorded high single digit growth rates. UnitedHealth's stock rallied past $100, a lifetime high, rising by over 35% during 2014. Taking into account the strong growth momentum in the Medicaid and Optum divisions, as well as promising prospects in international markets, we have revised our price estimate for the company's stock to $105.", "title": "A Look At The Factors Driving Our $105 Price Estimate For UnitedHealth", "url": "http://www.forbes.com/sites/greatspeculations/2015/02/23/a-look-at-the-factors-driving-our-105-price-estimate-for-unitedhealth/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2015-02-23T13:40:01-05:00", "type": "article"}, "twitter": {"image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "description": "The company posted solid growth figures in 2014, despite fears of an adverse impact from the implementation of the Affordable Care Act. The company's operating income and revenues both recorded high single digit growth rates. UnitedHealth's stock rallied past $100, a lifetime high, rising by over 35% during 2014. Taking into account the strong growth momentum in the Medicaid and Optum divisions, as well as promising prospects in international markets, we have revised our price estimate for the company's stock to $105.", "site": "@forbes", "card": "summary_large_image", "title": "A Look At The Factors Driving Our $105 Price Estimate For UnitedHealth"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Investing,Markets,Stocks", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/investing", "section": "Investing", "modified": "2015-02-23", "published": "2015-02-23", "id": "blogAndPostId/blog/post/25-142836"}, "news_keywords": "Investing,Markets,Stocks", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "The company posted solid growth figures in 2014, despite fears of an adverse impact from the implementation of the Affordable Care Act. The company's operating income and revenues both recorded high single digit growth rates. UnitedHealth's stock rallied past $100, a lifetime high, rising by over 35% during 2014. Taking into account the strong growth momentum in the Medicaid and Optum divisions, as well as promising prospects in international markets, we have revised our price estimate for the company's stock to $105."}, "_id": "\"57477af36914bd0286fcb8ff\"", "article_summary": ""}